Log in to save to my catalogue

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Metho...

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Metho...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153611377

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study

About this item

Full title

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study

Publisher

New York: Springer US

Journal title

Lung, 2023-12, Vol.201 (6), p.617-624

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Introduction
Methotrexate (MTX), a folate antagonist, is often used as second-line treatment in patients with sarcoidosis. Effectiveness of MTX has large inter-patient variability and at present therapeutic drug monitoring (TDM) of MTX is not possible. Upon administration, MTX is actively transported into cells and metabolized to its active form...

Alternative Titles

Full title

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153611377

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153611377

Other Identifiers

ISSN

0341-2040

E-ISSN

1432-1750

DOI

10.1007/s00408-023-00656-0

How to access this item